PlainRecalls
FDA Devices Moderate Class II Ongoing

VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood. Product Code: 6842905

Reported: May 31, 2023 Initiated: April 17, 2023 #Z-1628-2023

Product Description

VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood. Product Code: 6842905

Reason for Recall

Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis

Details

Units Affected
23751
Distribution
US Nationwide- Worldwide Distribution. Foreign: Australia Belgium Brazil Bermuda HM12 Canada L3R 4G5 Chile China Colombia Denmark France France Germany India Italy Japan Mexico Norway Portugal Russia Singapore 609917 Spain Sweden The Netherlands United Kingdom
Location
Raritan, NJ

Frequently Asked Questions

What product was recalled?
VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glycated hemoglobin A1c (DCCT/NGSP) and mmol/mol hemoglobin A1c (IFCC) in human whole blood. Product Code: 6842905. Recalled by Ortho-Clinical Diagnostics, Inc.. Units affected: 23751.
Why was this product recalled?
Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis
Which agency issued this recall?
This recall was issued by the FDA Devices on May 31, 2023. Severity: Moderate. Recall number: Z-1628-2023.